CTAG2 antibody (AA 121-210) (HRP)

Catalog No. ABIN721144

Product Details anti-CTAG2 Antibody (HRP)

Target: CTAG2 (Cancer/testis Antigen 2 (CTAG2))

Binding Specificity: AA 121-210

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CTAG2 antibody is conjugated to HRP

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Cross-Reactivity: Human

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human CTAG2

Isotype: IgG

Application Details

Application Notes: WB 1:300-5000
IHC-P 1:200-400

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handling Advice: Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for CTAG2

Target: CTAG2 (Cancer/testis Antigen 2 (CTAG2))

Alternative Name: CTAG2 (CTAG2 Products)

Synonyms: CAMEL antibody, CT2 antibody, CT6.2 antibody, CT6.2a antibody, CT6.2b antibody, ESO2 antibody, LAGE-1 antibody, LAGE2B antibody, cancer/testis antigen 2 antibody, CTAG2 antibody

Background:

Synonyms: CT2, ESO2, CAMEL, CT6.2, CT6.2a, CT6.2b, LAGE-1, LAGE2B, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1, CTAG2, LAGE1

Background: Testis and very low level in placenta and in some uterus samples. Observed in 25-50 % of tumor samples of melanomas, non-small-cell lung carcinomas, bladder, prostate and head and neck cancers.

Gene ID: 30848

UniProt: O75638